Last reviewed · How we verify

NCT02698514

The Ratio of Hypnotic to Analgesic Potency of Volatile Anesthetics

Completed Phase 3 Last updated 8 May 2018
What this trial tests

Phase 3 trial testing Sevoflurane in Anesthesia, General in 90 participants. Completed in 13 July 2016.

Timeline
16 February 2016
Primary endpoint
13 July 2016
13 July 2016

Quick facts

Lead sponsorKangbuk Samsung Hospital
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment90
Start date16 February 2016
Primary completion13 July 2016
Estimated completion13 July 2016
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Kangbuk Samsung Hospital

Who can join

Adults 19 to 65, any sex, with Anesthesia, General. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this clinical trial is to evaluate the ratio of hypnotic to analgesic potency of sevoflurane and desflurane at equi-minimum alveolar concentration using SPI and EEG analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sevoflurane

Trials testing the same drug.

Other recruiting trials for Anesthesia, General

Currently open trials in the same condition.

Other Kangbuk Samsung Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02698514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing